Tissue Regenix PLC's (LON:TRX) Gareth Jones caught up with Proactive's Andrew Scott to update on developments in the regenerative medical devices maker's second half.
''The focus is really on increasing throughput in our San Antonia facility in the United States to allow us to meet the demand that we see which is exceptional ... and it's really capitalising on that as we move forward into next year''
